ClinicalTrials.Veeva

Menu

A Longitudinal Study of Movement and Participation in Patients With Cerebral Palsy

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Completed

Conditions

Cerebral Palsy

Study type

Observational

Funder types

Other

Identifiers

NCT01903603
100-4545A3
NSC101-2314-B-182-004-MY3 (Other Identifier)

Details and patient eligibility

About

The primary goal of this study is to establish and evaluate an image-based biomarker for the impaired motor control and sensory information processing present in Cerebral palsy (CP) patients

Full description

Cerebral palsy (CP) may lead to various motor deficits, which further influence the activities and participation. It would be ideal to characterize neural network and motor control model in patients with CP that underlies their clinical behavior by identifying altered neural network and motor control associated with behavioral improvement. The aim of this study is to investigate the brain image and motor control in patients with CP evaluated by multimodal imaging studies utilizing multi-modal techniques and kinematic analysis.

This study includes a prospective longitudinal study of patients with CP over one-year. This study will be executed in 3 phases within 3 years: 1st phase (1st years): to establish the multimodal brain images and motor control, and clinical outcomes protocol with a prospective one-year follow-up study in healthy subjects; 2nd phase (2nd years): to establish the brain images and motor control, and clinical outcomes with a prospective one-year follow-up study in older patients with CP; and 3rd phase (3rd years): to establish the brain images and motor control, and clinical outcomes with a prospective one-year follow-up study in younger patients with CP. In a prospective longitudinal study, each participant received 3-times measurements: at the beginning, 6 months later, and one year after the first data collection point

Enrollment

80 patients

Sex

All

Ages

4 to 20 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • (1) Age: 4-20 y/o (2) Good cognition and cooperation (3) Healthy participants

Exclusion criteria

  • (1) Motor problems (2) Neurological, orthopedic, or progressive disorders (3) Active medical diseases, such as infection

Trial design

80 participants in 2 patient groups

Healthy Children
Description:
Inclusion criteria for healthy children were as follows: ages of 4-20 y/o ; good cognition and cooperation; and healthy children.
CP subjects
Description:
Inclusion criteria for subjects with brain damage by CP were as follows: a diagnosis of CP and aged 4-20 years old.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems